Exhibit 99.2

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2005		2004			2005		2004
Revenue	$	322,556	$	281,881		$	626,490	$	553,095
Costs and expenses:
Cost of operations		181,950		163,961			354,113		326,603
Development and engineering		14,457		12,991			29,097		24,087
Sales, marketing, general and administrative		83,533		83,298			165,670		160,292
Depreciation and amortization		17,541		13,148			34,045		25,733
Legal expense		4,283		2,215			8,443		4,252
Interest income		3,936		4,511			8,257		9,994
Interest expense		3,895		4,838			8,676		9,586
Other expense (income), net		1,712		(447	)		5,544		(484	)
Income before income tax provision		19,121		6,388			29,159		13,020
Income tax provision		2,955		613			3,144		1,544
Net income	$	16,166	$	5,775		$	26,015	$	11,476
Net income per common share:
Basic	$	0.05	$	0.02		$	0.08	$	0.04
Diluted	$	0.05	$	0.02		$	0.08	$	0.03
Weighted-average shares outstanding used in computing net income per common share:
Basic		337,303		322,919			331,318		316,965
Diluted		349,624		337,763			342,656		332,582

WebMD CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2005			2004			2005			2004
Revenues
Emdeon Business Services	$	191,514		$	166,037		$	377,247		$	329,816
Emdeon Practice Services		78,596			71,773			151,614			142,779
WebMD Health		40,465			31,852			74,040			58,161
Porex		20,397			20,737			40,253			39,158
Inter-segment eliminations		(8,416	)		(8,518	)		(16,664	)		(16,819	)
	$	322,556		$	281,881		$	626,490		$	553,095
Income before taxes, non-cash and other items
Emdeon Business Services	$	40,420		$	28,914		$	78,673		$	58,764
Emdeon Practice Services		8,183			1,771			12,580			3,122
WebMD Health		4,350			7,626			9,201			12,168
Porex		6,064			6,275			11,461			11,317
Corporate		(13,299	)		(14,228	)		(26,925	)		(27,533	)
Interest income		3,936			4,511			8,257			9,994
Interest expense		(3,895	)		(4,838	)		(8,676	)		(9,586	)
	$	45,759		$	30,031		$	84,571		$	58,246
Basic income per common share before taxes, non-cash and other items (a)	$	0.14		$	0.09		$	0.26		$	0.18
Diluted income per common share before taxes, non-cash and other items (a)	$	0.13		$	0.09		$	0.25		$	0.18
Taxes, non-cash and other items (b)
Depreciation and amortization		(17,541	)		(13,148	)		(34,045	)		(25,733	)
Non-cash advertising and distribution services and stock compensation		(3,102	)		(8,727	)		(7,380	)		(15,725	)
Legal expense		(4,283	)		(2,215	)		(8,443	)		(4,252	)
Income tax provision		(2,955	)		(613	)		(3,144	)		(1,544	)
Other income (expense), net		(1,712	)		447			(5,544	)		484
Net income	$	16,166		$	5,775		$	26,015		$	11,476
Net income per common share
Basic	$	0.05		$	0.02		$	0.08		$	0.04
Diluted	$	0.05		$	0.02		$	0.08		$	0.03
Weighted-average shares outstanding used in computing income per common share:
Basic		337,303			322,919			331,318			316,965
Diluted		349,624			337,763			342,656			332,582

(a)	Basic and diluted income per common share before taxes, non-cash and other items is based on the weighted-average shares outstanding used in computing basic and diluted income per common share.
(b)	Reconciliation of income before taxes, non-cash and other items to net income

WebMD CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

	June 30,		December 31,
	2005		2004
	(Unaudited)
Assets
Cash and cash equivalents	$	35,930	$	46,019
Short-term investments		152,005		61,675
Accounts receivable, net		220,817		204,447
Inventory		13,430		13,978
Prepaid expenses and other current assets		39,724		40,613
Total current assets		461,906		366,732
Marketable debt securities		323,182		511,864
Marketable equity securities		4,094		4,017
Property and equipment, net		112,118		89,677
Goodwill		1,028,592		1,010,564
Intangible assets, net		253,249		260,509
Other assets		44,822		48,871
	$	2,227,963	$	2,292,234
Liabilities and Stockholders’ Equity
Accounts payable	$	11,167	$	17,366
Accrued expenses		151,993		201,528
Deferred revenue		114,227		99,543
Total current liabilities		277,387		318,437
Convertible subordinated notes		350,000		649,999
Other long-term liabilities		5,334		1,283
Convertible redeemable exchangeable preferred stock		98,416		98,299
Stockholders’ equity		1,496,826		1,224,216
	$	2,227,963	$	2,292,234

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Six Months Ended
	June 30,
	2005			2004
Cash flows from operating activities:
Net income	$	26,015		$	11,476
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		34,045			25,733
Amortization of debt issuance costs		1,333			1,498
Non-cash advertising and distribution services		5,013			11,284
Non-cash stock based compensation		2,367			4,441
Bad debt expense		3,722			2,914
Loss (gain) on investments		3,642			(363	)
Gain on sale of property and equipment		—			(121	)
Loss on redemption of convertible debt		1,902			—
Changes in operating assets and liabilities:
Accounts receivable		(18,350	)		(1,724	)
Inventory		547			206
Accounts payable		(5,881	)		(900	)
Accrued expenses		(2,450	)		(19,179	)
Deferred revenue		9,501			6,320
Prepaid expenses and other, net		1,294			(937	)
Net cash provided by operating activities		62,700			40,648
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		190,673			1,011,914
Purchases of available-for-sale securities		(94,350	)		(1,103,876	)
Purchases of property and equipment		(38,717	)		(12,047	)
Proceeds received from sale of property and equipment		400			417
Cash paid in business combinations, net of cash acquired		(74,110	)		(58,060	)
Net cash used in investing activities		(16,104	)		(161,652	)
Cash flows from financing activities:
Redemption of convertible debt		(86,694	)		—
Proceeds from issuance of common stock		31,437			25,011
Net proceeds from issuance of preferred stock		—			98,115
Payments of notes payable and other		(304	)		(257	)
Purchases of treasury shares		—			(4,877	)
Net cash (used in) provided by financing activities		(55,561	)		117,992
Effect of exchange rates on cash		(1,124	)		(200	)
Net decrease in cash and cash equivalents		(10,089	)		(3,212	)
Cash and cash equivalents at beginning of period		46,019			39,648
Cash and cash equivalents at end of period	$	35,930		$	36,436